Establishes an epinephrine auto-injector affordability program to provide low-cost epinephrine auto-injectors; requires insurance coverage for epinephrine auto-injectors and capping the co-pay or deductible for such at sixty dollars; makes failure to comply with the epinephrine auto-injectors affordability program a deceptive business practice; makes an appropriation therefor.
Relates to the emergency use of epinephrine auto-injector devices; increases the maximum population size for counties, cities, towns and villages which are permitted to purchase, acquire, possess and use epinephrine auto-injector devices.
Relates to the emergency use of epinephrine auto-injector devices; increases the maximum population size for counties, cities, towns and villages which are permitted to purchase, acquire, possess and use epinephrine auto-injector devices.
Provides for the use of glucagon emergency injection kits by persons other than licensed health care professionals; provides for expanded use of epinephrine auto-injector devices in schools in emergency circumstances.